Once again drug companies are in the news with another failed attempt to provide health care by way of a drug. Our medical system is a sick-care or crisis-care system more than a health-care system. While it is very good at preventing death in emergency situations, it is lacking when it comes to caring for many chronic and progressive conditions. Read this article from USA Today:
The Food and Drug Administration says there is a clear association between the nerve-blocking medications and incidences of joint failure that led the agency to halt studies of the drugs in 2010. However, the agency also notes that those side effects were less common when the drugs were used at lower doses, potentially leaving the door open for future use. The agency released its safety analysis ahead of a public meeting next week where outside experts will discuss the drugs’ safety.
On Monday, Pfizer Inc., Johnson & Johnson and Regeneron Pharmaceuticals will make their case to continue studies of the drugs, with safety precautions to protect patients.
The request to restart testing is unusual, since drugmakers often abandon research on experimental drugs that appear to have safety issues. However, with more than 50 million U.S. adults diagnosed with arthritis — one in five — the potential multibillion dollar market opportunity may be too big to ignore.
If the drugs eventually win FDA approval though, they may be used for much narrower indications than initially envisioned. The FDA’s proposed questions to its experts appear designed to limit any future testing of the drugs.
“Considering what is known thus far about the risks and benefit associated with this class of biologic agents, are there any populations for which further clinical development would be acceptable?” asks one agency discussion question.
Drugmakers once touted the drugs, known as nerve growth factor inhibitors, as a potential breakthrough for treating osteoarthritis, back pain and other chronic pain conditions. For more than a century doctors have treated pain with familiar painkillers like aspirin and Advil, or powerful opiate-based drugs. Both approaches can be problematic. Anti-inflammatory painkillers like Advil can cause stomach bleeding, while opiates carry a high risk of addiction
The injectable nerve-silencing drugs offered a new approach, by blocking proteins that control pain sensations throughout the body.
But problems with the drugs began to emerge in the summer of 2010. Beginning in June, Pfizer halted studies of its experimental injection tanezumab in patients with osteoarthritis, low back pain and diabetic nerve pain. The action was requested by the Food and Drug Administration, after researchers reported that osteoarthritis actually worsened in some patients, causing joint failure in some cases.
You see – we shouldn’t be caring for these “conditions” but rather caring for the individual. Emphasis on proper lifestyle prevents chronic conditions and is vastly more healthy than trying to treat a diseased state. This is as futile as trying to remove darkness from a dark room.
Of course, there is a time for medicine and every situation is different. However, in cases like this article cites, too often medicine takes the narrow path of trying to resolve a symptom rather than addressing the cause.
If you or someone you love is looking for help with chronic pain – call us today. We’re here to help!
Your St. Paul Chiropractor,
- Once-Promising Arthritis Drugs Linked To Bone Decay By FDA (huffingtonpost.com)
- Who’s Beating Back Pain in America and How Are They Doing It? (lifestylechirocenter.com)
- Shortening the Road to Recovery After an Automobile Injury: Your Chiropractor Can Help. (lifestylechirocenter.com)